Flow cytometric analysis of Human CD83 expression on human monocytes-derived mature dendritic cells. Human monocytes-derived mature dendritic cells were stained with Brilliant Violet 711™ Mouse Anti-Human CD11c Antibody and either FITC Rabbit IgG Isotype Control (left panel) or SDT FITC Rabbit Anti-Human CD83 Antibody (right panel) at 5 μl/test. Flow cytometry and data analysis were performed using BD FACSymphony™ A1 and FlowJo™ software.
Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | CD83 |
| Immunogen | Recombinant Protein |
| Accession | Q01151 |
| Clone Number | S-4523-8 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Isotype Control | S0B8556 |
| Application | FCM |
| Reactivity | Hu |
| Positive Sample | mDC |
| Purification | Protein A |
| Concentration | 0.2 mg/ml |
| Conjugation | FITC |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 1% BSA, 0.09% sodium azide |
| Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
| application | dilution | species |
| FCM | 5μl per million cells in 100μl volume | Hu |
Background
CD83 is a ~45 kDa, heavily glycosylated type-I transmembrane glycoprotein of the immunoglobulin superfamily that is encoded on human chromosome 6 and expressed chiefly on mature dendritic cells, Langerhans cells and activated lymphocytes, where it serves as a key maturation marker whose extracellular V-set Ig-like domain can dimerize via a membrane-proximal cysteine and whose membrane-bound form drives potent T-cell stimulation while its proteolytically released soluble counterpart (sCD83) exerts potent immunosuppressive effects by inhibiting dendritic-cell maturation and cytokine production, thereby modulating both the initiation and resolution of adaptive immune responses.
Picture
Picture
FC
